文献速递心力衰竭与心肌病

深内含子MYBPC3变异通过放大自然错误剪接事件导致肥厚型心肌病

Natural Missplicing Events Amplified by an Elusive Deep-Intronic MYBPC3 Variant Cause Hypertrophic Cardiomyopathy.
PubMed 文献 · Circulation · 2026-09-15

该研究在基因型阴性HCM患者中鉴定出深内含子变异MYBPC3 c.2308+227G>A,虽被SpliceAI预测为良性,但通过家系共分离、剪接试验和单倍型分析证实其致病性。该变异不改变经典剪接位点,而是促进使用预先存在的隐蔽剪接位点,产生截短蛋白,从而拓展了深内含子变异致HCM的机制。

要点

  • MYBPC3 c.2308+227G>A被SpliceAI预测为良性(Δ评分0.03),但实际致病。
  • 该变异通过激活预先存在的隐蔽供体/受体位点导致错误剪接,产生截短蛋白。
  • 对遗传病因未明的HCM患者,应考虑检测此类难以发现的剪接改变变异。

核心结论

  • MYBPC3 c.2308+227G>A是一种致病性剪接改变变异,通过放大自然错误剪接事件导致HCM。

研究设计与样本

  • 研究采用大规模平行测序在西班牙Salamanca基因型阴性HCM患者队列中鉴定变异,并进行了遗传检测、临床评估、家系研究、剪接试验和单倍型重建等广泛分析。

主要发现

  • 共鉴定35个无亲缘关系的HCM先证者携带c.2308+227G>A,加上27个家系的46名亲属,共81名确认携带者。
  • 81名携带者中56名(69%)符合HCM诊断标准(66%男性;平均年龄53±15岁)。
  • 至60岁时,女性累积外显率估计为81%,男性为96%。
  • 20个信息家系的联合LOD评分为5.51,强烈支持共分离。
  • 先证者随访中,与携带其他致病MYBPC3变异队列相比,心力衰竭、心律失常事件、心房颤动或死亡率无显著差异。

临床怎么用

  • 对于遗传病因未明的HCM患者,应考虑检测难以发现的MYBPC3剪接改变变异。
  • 深内含子变异可能被预测工具误判为良性,需结合家系共分离和功能试验综合判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Disruption of MYBPC3 precursor mRNA splicing is a frequent genetic cause of hypertrophic cardiomyopathy (HCM). Most often, it reflects changes at canonical sites or the creation of novel splice sites. Prediction tools usually prioritize splice variants with lower efficiency when they are distant from canonical sites. These elusive variants may explain HCM in patients considered genotype-negative after DNA testing. METHODS: Massively parallel sequencing identified the previously unreported deep-intronic variant MYBPC3 c.2308+227G>A in a cohort of genotype-negative patients with HCM from Salamanca, Spain. SpliceAI predicted a benign effect (Δ score, 0.03). However, its recurrent detection prompted us to conduct extensive analyses to investigate its pathogenicity, including genetic testing, clinical assessment, family studies, splicing assays, and haplotype reconstruction. RESULTS: We identified 35 unrelated HCM probands carrying c.2308+227G>A, plus 46 relatives from 27 families, yielding 81 confirmed carriers. Of these, 56 (69%) met diagnostic criteria for HCM (66% male; mean age, 53±15 years). By age 60 years, cumulative penetrance was estimated to be 81% in women and 96% in men. The combined logarithm of the odds score of 5.51 across 20 informative families provided strong evidence of cosegregation. During follow-up of probands, no significant differences were observed in heart failure, arrhythmic events, atrial fibrillation, or mortality when compared with cohorts carrying other pathogenic MYBPC3 variants. Blood splicing assays, confirmed in cardiac tissue, showed that c.2308+227G>A disrupts splicing by the use of pre-existing cryptic donor (c.2308+299) and acceptor (c.2309-580) splice sites, generating 2 misspliced mRNAs with partial intron retention or cryptic exon inclusion, which encode truncated proteins. These cryptic sites are the leading natural, unannotated missplicing events in intron 23, and some of the most frequent across the whole MYBPC3 precursor mRNA, as revealed by SpliceVault analysis of RNA sequencing databases. This deep-intronic variant does not alter essential splice motifs but promotes the use of pre-existing cryptic sites, likely through gain of splicing regulatory enhancer elements. The identification of a shared haplotype among HCM probands carrying this variant explains its recurrent detection, consistent with an ancient founder effect. CONCLUSIONS: MYBPC3 c.2308+227G>A is a pathogenic splice-altering variant that causes HCM by amplifying natural missplicing events. These background splicing errors help explain how this elusive variant disrupts splicing without creating novel essential splice sites, thereby expanding the known mechanisms by which deep-intronic variants alter MYBPC3 splicing and ultimately contribute to HCM pathogenesis. Elusive MYBPC3 splice-altering variants should be considered in HCM patients with an unresolved genetic origin of disease.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Gallego-Delgado M, Lorenzo Hernández SM, García Hernández S, et al. Natural Missplicing Events Amplified by an Elusive Deep-Intronic MYBPC3 Variant Cause Hypertrophic Cardiomyopathy. Circulation. 2026. PMID: 42741831. doi:10.1161/CIRCULATIONAHA.125.078812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。